Net Sales

-25.7%

Q4 2024 net sales dropped to 9,157 thousand USD from 12,333 thousand USD in Q4 2023, driven by persistent weakness in key OEM channels—especially from the decline in sales to PendoTECH—and reduced demand compared to prior periods where a 20% decline had already signaled deteriorating performance. " "

Domestic Revenue

-14.8%

Domestic revenue fell to 5.74 thousand USD from 6.73 thousand USD, reflecting ongoing challenges in the U.S. market such as lower OEM and Filshie device sales; this builds on the earlier Q3 2024 decline of 21.7%, showing sustained pressure in domestic sales channels. " "

Outside U.S. Revenue

-38.7%

Outside U.S. revenue decreased to 3.42 thousand USD from 5.59 thousand USD, a sharper decline than the 17.6% drop seen in Q3 2024, due to further erosion in regional performance and diminished benefits from favorable foreign exchange rates. " "

Operating Income

-25.7%

Operating income declined to 2,930 thousand USD from 3,944 thousand USD, primarily as a result of lower sales volume reducing gross margins and increased costs from litigation and overhead expenses—a continuation and deepening of the cost pressures noted in Q3 2024. " "

Net Income & EPS

Net Income: -32% / EPS: -27%

Net income fell to 2,902 thousand USD from 4,286 thousand USD (32% decline) and diluted EPS dropped from 1.18 USD to 0.857 USD (27% decline) due to lower revenues and gross profit compounded by higher operating expenses; share repurchases partly mitigated the EPS drop relative to net income, building on similar challenges observed in previous periods. " "